During the recent session, Elanco Animal Health Inc (NYSE:ELAN)’s traded shares were 2.99 million, with the beta value of the company hitting 1.41. At the last check today, the stock’s price was $13.88, reflecting an intraday loss of -5.26% or -$0.77. The 52-week high for the ELAN share is $18.80, that puts it down -35.45 from that peak though still a striking 38.62% gain since the share price plummeted to a 52-week low of $8.52. The company’s market capitalization is $6.86B, and the average intraday trading volume over the past 10 days was 3.54 million shares, and the average trade volume was 5.34 million shares over the past three months.
Elanco Animal Health Inc (ELAN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. ELAN has a Sell rating from 1 analyst(s) out of 5 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.12.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Elanco Animal Health Inc (NYSE:ELAN) trade information
Elanco Animal Health Inc (ELAN) registered a -5.26% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -5.26% in intraday trading to $13.88, hitting a weekly high. The stock’s 5-day price performance is -3.55%, and it has moved by -5.46% in 30 days. Based on these gigs, the overall price performance for the year is 17.12%. The short interest in Elanco Animal Health Inc (NYSE:ELAN) is 13.3 million shares and it means that shorts have 2.7 day(s) to cover.
The consensus price target of analysts on Wall Street is $26, which implies an increase of 46.62% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $16 and $37 respectively. As a result, ELAN is trading at a discount of -166.57% off the target high and -15.27% off the low.
Elanco Animal Health Inc (ELAN) estimates and forecasts
Statistics show that Elanco Animal Health Inc has underperformed its competitors in share price, compared to the industry in which it operates. Elanco Animal Health Inc (ELAN) shares have gone down -14.22% during the last six months, with a year-to-date growth rate less than the industry average at 2.25% against 16.90. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -33.30% this quarter and then jump 100.00% in the quarter after that. In the rating firms’ projections, revenue will increase 0.20% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 1.03B as predicted by 9 analyst(s). Meanwhile, a consensus of 9 analyst(s) estimates revenue growth to 1.01B by the end of current fiscal year.
While earnings are projected to return 2.98% in 2024, the next five years will return 8.70% per annum.
ELAN Dividends
Elanco Animal Health Inc is due to release its next quarterly earnings on 2024-Nov-05. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Elanco Animal Health Inc (NYSE:ELAN)’s Major holders
Elanco Animal Health Inc insiders own 0.66% of total outstanding shares while institutional holders control 99.28%, with the float percentage being 99.94%. DODGE & COX is the largest shareholder of the company, while 553.0 institutions own stock in it. As of 2024-06-30, the company held over 83.58 million shares (or 16.9471% of all shares), a total value of $1.21 billion in shares.
The next largest institutional holding, with 52.8 million shares, is of PRIMECAP MANAGEMENT CO/CA/’s that is approximately 10.7062% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $761.94 million.
